Phase II Study of Preoperative Chemoradiotherapy with Oxaliplatin, Infusional 5‐Fluorouracil, and Cetuximab Followed by Postoperative Docetaxel and Cetuximab in Patients with Adenocarcinoma of the Esophagus: A Trial of the ECOG‐ACRIN Cancer Research Group (E2205)

Lignende værker

• Intergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5‐Fluorouracil, and Leucovorin Versus Oxaliplatin, 5‐Fluorouracil, Leucovorin, and Bevacizumab for Patients with Stage II or III Rectal Cancer Receiving Preoperative Chemoradiation: A Trial of the ECOG‐ACRIN Research Group (E5204)
  af: Chakravarthy, A. Bapsi, et al.
  Udgivet: (2019)
• Phase I Study of Preoperative Radiation Therapy with Concurrent Infusional 5-Fluorouracil and Oxaliplatin followed by Surgery and Postoperative 5- Fluorouracil plus Leucovorin for T3/4 Rectal Adenocarcinoma: ECOG E1297
  af: Rosenthal, David I., et al.
  Udgivet: (2008)
• Effect of docetaxel + oxaliplatin + S-1 and docetaxel + cisplatin + fluorouracil on treatment of advanced gastric cancer
  af: Wei Li, et al.
  Udgivet: (2016-09-01)
• Phase I Trial of Oxaliplatin, Infusional 5-Fluorouracil, and Leucovorin (FOLFOX4) With Erlotinib and Bevacizumab in Colorectal Cancer
  af: Messersmith, Wells A., et al.
  Udgivet: (2010)
• Phase II Trial of Preoperative Radiation With Concurrent Capecitabine, Oxaliplatin, and Bevacizumab Followed by Surgery and Postoperative 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX), and Bevacizumab in Patients With Locally Advanced Rectal Cancer: 5-Year Clinical Outcomes ECOG-ACRIN Cancer Research Group E3204
  af: Landry, Jerome C., et al.
  Udgivet: (2015)